‹ All issues
IMRAD Reads · The Quarterly Craft Review · Issue 01 — Q3 2026

The best-written science and medicine of the quarter — read like a professional.

Four times a year we gather the finest writing in science and medicine, chosen for craft rather than news, with a working writer's notes on exactly why each piece works — and what you can steal from it.

Read like a scientist. Write like a professional.
Editor's note

Three of this issue's picks wrestle with the same hard problem: how do you write honestly about something science hasn't finished figuring out? A measles essay that never raises its voice. A feature on antidepressants that makes not knowing the whole story. A survey of public trust that refuses the easy villain. The lesson running through all of them is that authority in science writing doesn't come from certainty — it comes from precision about the limits of what you know. That is also, not coincidentally, what critical appraisal trains you to do.

The shortlist — worth your time this quarter
Elizabeth Bruenig · The Atlantic · 13 Feb 2026
The most disciplined piece of risk communication published this year — a hypothetical built entirely from real reporting.
Lynne Peeples · Nature · 26 Aug 2026
Takes the drug hundreds of millions take and makes its central mystery — we still can't fully explain the mechanism — the spine of the story.
Helen Pearson · Nature · 1 Jul 2026
A data-first treatment of a question usually answered with anecdote — a model for letting the numbers, not the headline, set the tone.
Roxanne Khamsi · Nature · 26 Jun 2026
Explains epigenome editing — switching genes off without cutting DNA — without a single mangled metaphor. A clinic in making the technical legible.
Elie Dolgin · Nature · 12 Aug 2026
A masterclass in the skeptical profile: takes an extraordinary claim seriously enough to report it fully, and rigorously enough to weigh it fairly.
Elizabeth Quill · Nature · 4 Aug 2026
Handles the longevity beat — a field thick with hype — by staying scrupulously close to what the evidence actually supports.
Matthew Hutson · Nature · 1 Sep 2026
A piece about homogenization that is itself a small argument for voice — worth reading for what it demonstrates as much as what it says.
How a professional reads it
Deep read #1 — narrative

This is how a child dies of measles

Elizabeth Bruenig · The Atlantic · 13 Feb 2026

What she did. Bruenig wanted to convey what measles actually does to a child — without a real dead child to write about, and without inventing one dishonestly. Her solution: a hypothetical account of a real phenomenon, built from careful reporting (pediatric infectious-disease specialists, epidemiologists, and the clinical literature on the disease's progression, including SSPE — the fatal neurological complication that can surface years later). She wrote it in the second person. You plant your daughter on the couch, put Bluey on the TV, and the illness proceeds from there.

  • Second person turns a statistic into an address. A case-fatality rate is a number you file away; "your daughter" is a sentence you can't put down. Bruenig didn't report new facts — she changed the grammatical distance to them. When you need a reader to feel an effect size, ask whether they're standing in the right place relative to it.
  • The mundane detail is the delivery vehicle for the clinical one. Bluey on the TV, a blanket on the couch — the domestic texture is what makes the medical description land. Data without a room to sit in evaporates. Give your evidence a setting.
  • Empathy for the "wrong" character is a credibility move, not a soft one. The mother is anxious and misinformed, never a caricature. A writer who scores easy points against a subject signals the argument couldn't survive a fair fight. Refusing the cheap shot is how you earn the hard conclusion.
  • Restraint carries the horror. The prose never shouts. The material is unbearable, so the sentences don't have to be. Turning up the volume on already-alarming facts reads as manipulation; the flat register reads as truth.
The appraisal tie-in. This is risk communication written the way a good limitations paragraph is written: it states exactly what is known, refuses to overclaim, and trusts the reader to do the arithmetic of fear themselves.
Deep read #2 — explanatory

The baffling science of SSRIs: how do they really work?

Lynne Peeples · Nature · 26 Aug 2026

What she did. Peeples opens on a paradox and never lets go of it: every year millions start a drug whose therapeutic effects can't be fully explained, for a condition that can't be objectively diagnosed with a lab test. From there she dismantles the tidy "chemical imbalance" story most readers carry — walking through the tryptophan-depletion experiments that undercut the simple serotonin-deficiency account — and lays out the competing explanations (neuroplasticity, BDNF signalling, altered perception, placebo) as potentially complementary rather than rival, closing on the honest line that none yet offers a complete explanation.

  • A paradox is a better engine than a summary. Most explainers open by telling you what they'll explain. Peeples opens with a contradiction you can feel, and the whole piece becomes its resolution. Find the thing that shouldn't be true and lead with it.
  • Write uncertainty as the subject, not the caveat. The weak version buries "we don't fully know how they work" in paragraph nine. Peeples makes it the spine. When the honest answer is "it's unsettled," that is the story — stop apologising for it in a subordinate clause.
  • Correct a popular belief by re-enacting the experiment, not asserting. She doesn't write "the serotonin hypothesis is outdated." She shows the tryptophan-depletion result and lets the reader retire the idea themselves. Earned conclusions beat announced ones — the same reason CONSORT wants the method before the claim.
  • "Complementary, not competing" is a sophistication signal. Framing rival hypotheses as possibly-all-partly-true, rather than staging a winner-take-all fight, is what separates a writer who understands the science from one covering a horse race. Resist the tidy verdict when the evidence doesn't offer one.
The appraisal tie-in. This is the whole discipline in miniature: separate the marketed story from the evidentiary one, name what's established and what's contested, and let the strength of the claim match the strength of the data.
One term, decoded — Spin

Spin

In critical appraisal, spin is the gap between what a study found and how its abstract, press release, or news write-up makes it sound. Classic forms: leading with a non-significant secondary outcome as if it were the headline; reporting a relative risk reduction ("cuts risk 50%!") while hiding a trivial absolute one (2% to 1%); or concluding a drug "may help" when the trial simply failed to show it did. Spin is why a professional reader always walks the claim back to the numbers before believing the sentence. Notice how every deep read above wins by doing the opposite of spin — matching the volume of the language to the weight of the evidence. Detecting spin in others is a skill; refusing it in your own writing is a habit.

A version of this decode lives in the IMRAD question bank as a Critical Appraisal item.
This quarter's assignment

Take the abstract of any paper you read this month. Underline every phrase that makes a claim, and beside each, write the actual number it rests on. Where you can't find the number, you've found the spin.

Get IMRAD Reads by email

One issue a quarter. The best-written science and medicine, annotated. No spam, no filler — unsubscribe anytime.

Subscribe →